At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 449 enrolled
Drug / intervention
Traumeel S ointment +2 moredrug
Likely dose
Traumeel S ointment 2 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Controlled, Multi-center Study on the Effectiveness of Traumeel S (Both Ointment and Gel) in Terms of Pain and Function Compared With a Topical NSAID in Athletes With Acute Ankle Sprain
In Brief
A Phase 3 clinical trial evaluating Traumeel S ointment, Traumeel S gel, and 1 other intervention for Sprain of Ankle. Completed, enrolled 449 participants across 1 site.
Detailed Summary
The objective of this study is to determine the efficacy of Traumeel S (both ointment and gel) compared to another antiinflammatory drug called Diclofenac in patients with a sprained ankle.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSprain of Ankle
CountriesSpain
Collaborators--
Timeline
Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2009
First PostedFeb 2010
Primary CompletionSep 2011
Study CompletionMar 2012
TodayJul 2026
First PostedFeb 10, 2010
Enrollment StartAug 1, 2009
Primary CompletionSep 1, 2011
Study CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 16.4 years ago
Interventions
Traumeel S ointmentdrug
2 g, 3 times daily topical during 14 days
Traumeel S geldrug
2 g, 3 times daily topical during 14 days
Diclofenac geldrug
2 g, 3 times daily topical during 14 days